0,972  0,001  Antimutagenic
0,965  0,002  Genotoxic
0,920  0,002  NOS2 expression inhibitor
0,913  0,003  Caspase 9 stimulant
0,905  0,004  Mutagenic
0,900  0,004  Chemoprotective
0,890  0,003  Chemopreventive
0,878  0,002  Antihypoxic
0,876  0,004  Antihypercholesterolemic
0,876  0,009  Alpha-glucosidase inhibitor
0,867  0,009  Transcription factor NF kappa B inhibitor
0,826  0,004  UGT1A9 substrate
0,821  0,002  Amylase inhibitor
0,800  0,002  Melanin inhibitor
0,786  0,007  Carcinogenic
0,784  0,008  Antidiabetic
0,784  0,008  Cyclophilin D inhibitor
0,776  0,004  Proliferative diseases treatment
0,777  0,007  Radioprotector
0,772  0,005  Antioxidant
0,771  0,004  Cardioprotectant
0,767  0,003  UGT1A1 substrate
0,778  0,018  Antiinflammatory
0,770  0,020  Apoptosis agonist
0,749  0,004  DNA damaging
0,752  0,012  Teratogen
0,738  0,004  Monophenol monooxygenase inhibitor
0,733  0,006  Antibacterial
0,719  0,004  Angiogenesis stimulant
0,727  0,013  Embryotoxic
0,726  0,012  TNF expression inhibitor
0,708  0,005  Hypoglycemic
0,705  0,005  Free radical scavenger
0,702  0,003  Interleukin agonist
0,692  0,005  Caspase 3 stimulant
0,682  0,009  Antithrombotic
0,674  0,005  Antipyretic
0,673  0,005  Ulceration
0,670  0,003  Xanthine oxidase inhibitor
0,661  0,002  Antihemorrhagic
0,672  0,016  Antileukemic
0,655  0,009  Cytostatic
0,654  0,008  Antiparasitic
0,640  0,003  Mediator release inhibitor
0,647  0,013  Cholesterol antagonist
0,642  0,008  NOS3 expression inhibitor
0,640  0,009  Cytotoxic
0,647  0,019  Antineoplastic (colorectal cancer)
0,634  0,006  Apoptosis antagonist
0,644  0,025  Antineoplastic (lung cancer)
0,620  0,006  UDP-glucuronosyltransferase substrate
0,620  0,007  Vasodilator, coronary
0,608  0,007  Tumour necrosis factor alpha release inhibitor
0,620  0,020  Antineoplastic (colon cancer)
0,609  0,010  Hepatic disorders treatment
0,600  0,003  VCAM1 expression inhibitor
0,602  0,006  Antihelmintic
0,597  0,010  Nitric oxide antagonist
0,602  0,015  Sensitization
0,614  0,033  Antineoplastic (breast cancer)
0,608  0,028  CYP3A4 substrate
0,572  0,004  Antihypotensive
0,573  0,007  Vascular (periferal) disease treatment
0,571  0,006  Antihypertriglyceridemic
0,570  0,009  DNA synthesis inhibitor
0,565  0,005  ICAM1 expression inhibitor
0,574  0,020  Immunostimulant
0,557  0,009  Antineoplastic (osteosarcoma)
0,553  0,006  Antineoplastic (sarcoma)
0,551  0,004  Alkylator
0,548  0,003  Antifungal enhancer
0,543  0,005  Hepatoprotectant
0,533  0,005  NOS3 expression enhancer
0,546  0,019  Antineoplastic (melanoma)
0,541  0,016  AR expression inhibitor
0,531  0,007  UGT2B4 substrate
0,536  0,013  Antiamyloidogenic
0,528  0,006  Skin whitener
0,537  0,016  Antifungal
0,529  0,009  Antineoplastic (lymphoma)
0,524  0,004  Protein kinase stimulant
0,537  0,022  Antineoplastic (ovarian cancer)
0,513  0,003  AMP-activated protein kinase stimulant
0,518  0,010  RNA-directed DNA polymerase inhibitor
0,513  0,007  Interleukin 2 agonist
0,531  0,025  Immunosuppressant
0,511  0,005  Interferon gamma antagonist
0,509  0,003  Beta glucuronidase inhibitor
0,508  0,006  Septic shock treatment
0,526  0,026  Antipruritic, allergic
0,500  0,003  Hexokinase inhibitor
0,499  0,032  Prostate cancer treatment
0,470  0,005  Hemostatic
0,474  0,011  Radiosensitizer
0,483  0,021  Antineoplastic (glioma)
0,475  0,017  Antineoplastic (glioblastoma multiforme)
0,489  0,038  CYP2C9 substrate
0,456  0,006  Sulfotransferase substrate
0,473  0,024  Antineoplastic (pancreatic cancer)
0,465  0,022  Antineoplastic (non-small cell lung cancer)
0,450  0,009  Non-steroidal antiinflammatory agent
0,466  0,027  Antineoplastic (cervical cancer)
0,448  0,008  Platelet adhesion inhibitor
0,440  0,004  Aldose reductase substrate
0,461  0,025  Antineoplastic (brain cancer)
0,437  0,004  Expectorant
0,489  0,059  Antineoplastic (solid tumors)
0,436  0,008  Lipid peroxidase inhibitor
0,456  0,030  Immunomodulator
0,432  0,006  Antidote
0,454  0,035  Respiratory analeptic
0,420  0,003  Selectin antagonist
0,424  0,009  Topoisomerase II inhibitor
0,431  0,018  Antineoplastic (liver cancer)
0,413  0,004  NADH dehydrogenase inhibitor
0,408  0,005  Antitussive
0,425  0,021  Amyloid beta aggregation inhibitor
0,406  0,005  Neurotrophic factor enhancer
0,409  0,013  Antiviral (Herpes)
0,420  0,027  Antidiabetic (type 2)
0,392  0,005  Topoisomerase I inhibitor
0,409  0,023  Antidiabetic symptomatic
0,398  0,020  Antineoplastic (small cell lung cancer)
0,375  0,003  Photosensitizer
0,380  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,393  0,026  UGT1A6 substrate
0,394  0,031  Antiprotozoal (Leishmania)
0,368  0,006  Antihelmintic (Nematodes)
0,411  0,050  Angiogenesis inhibitor
0,358  0,004  DNA repair enzyme inhibitor
0,382  0,028  Antineoplastic (renal cancer)
0,361  0,007  Antineoplastic antibiotic
0,368  0,014  Antineoplastic (squamous cell carcinoma)
0,374  0,021  Cyclic AMP phosphodiesterase inhibitor
0,393  0,041  Spasmolytic
0,357  0,014  Antipruritic, non-allergic
0,353  0,012  Antineoplastic (gastric cancer)
0,349  0,009  Acute respiratory distress syndrome (ARDS) treatment
0,351  0,018  Antiviral (Influenza)
0,339  0,008  Aldehyde dehydrogenase inhibitor
0,345  0,018  DNA methylase inhibitor
0,326  0,008  Cystathionine beta-synthase inhibitor
0,351  0,033  Vasodilator
0,332  0,015  Peptidyltransferase inhibitor
0,365  0,051  Antimycobacterial
0,378  0,065  Stroke treatment
0,345  0,037  Myocardial infarction treatment
0,372  0,065  Vasodilator, peripheral
0,316  0,009  Carcinogenic, group 2B
0,347  0,043  Antineoplastic (multiple myeloma)
0,309  0,007  Topoisomerase II alpha inhibitor
0,321  0,019  Antineoplastic (carcinoma)
0,351  0,050  CYP2C19 substrate
0,298  0,001  Sodium/glucose cotransporter inhibitor
0,347  0,052  Analeptic
0,379  0,086  Histamine release inhibitor
0,302  0,011  Nitric-oxide synthase stimulant
0,295  0,005  Choleretic
0,295  0,006  ATPase inhibitor
0,343  0,058  5 Hydroxytryptamine release stimulant
0,290  0,007  Antibiotic
0,330  0,052  Hypoxia-inducible factor 1 alpha inhibitor
0,280  0,007  Cyclooxygenase 3 inhibitor
0,290  0,019  UGT2B15 substrate
0,282  0,011  Cell wall synthesis inhibitor
0,309  0,040  Antineoplastic (lymphocytic leukemia)
0,321  0,053  Antineoplastic (endocrine cancer)
0,280  0,012  Antiprotozoal (Coccidial)
0,279  0,012  Psychosexual dysfunction treatment
0,311  0,048  Transcription factor STAT3 inhibitor
0,270  0,007  Antifungal (Cryptococcus)
0,353  0,091  Antiprotozoal
0,268  0,009  Mannose-6-phosphate isomerase inhibitor
0,362  0,113  Antiarthritic
0,293  0,045  Antiulcerative
0,267  0,020  Interleukin 6 antagonist
0,276  0,032  UGT2B7 substrate
0,278  0,035  DNA methyltransferase I inhibitor
0,269  0,026  Restenosis treatment
0,298  0,057  Transcription factor STAT inhibitor
0,251  0,013  Interleukin 4 antagonist
0,262  0,025  Diabetic nephropathy treatment
0,240  0,004  Phosphodiesterase 6D inhibitor
0,248  0,016  DNA intercalator
0,347  0,118  5 Hydroxytryptamine release inhibitor
0,229  0,001  Sodium/glucose cotransporter 2 inhibitor
0,248  0,020  Antidiarrheal
0,242  0,014  UDP-glucose 4-epimerase inhibitor
0,235  0,009  CF transmembrane conductance regulator agonist
0,280  0,055  Antineoplastic (bladder cancer)
0,269  0,045  Antineoplastic enhancer
0,233  0,010  Dementia treatment
0,232  0,010  Antineoplastic, alkylator
0,225  0,007  Antiviral (Influenza B)
0,232  0,015  Antibacterial (Helicobacter pylori)
0,227  0,010  Vascular dementia treatment
0,219  0,005  Toll-Like receptor 4 antagonist
0,224  0,011  Carbonic anhydrase XIII inhibitor
0,221  0,008  Vanilloid 1 agonist
0,286  0,073  Lipoprotein disorders treatment
0,247  0,036  Insulin sensitizer
0,228  0,018  Cell adhesion inhibitor
0,230  0,021  Glutathione S-transferase substrate
0,229  0,024  Insulin secretagoues
0,230  0,031  Antiviral (Influenza A)
0,221  0,022  DNA polymerase I inhibitor
0,230  0,032  Liver fibrosis treatment
0,209  0,011  Mucolytic
0,203  0,006  Interferon agonist
0,223  0,029  Antiviral (Ebola)
0,215  0,024  Antirickettsial
0,195  0,004  Antibiotic Glycopeptide-like
0,198  0,011  Chronic obstructive bronchitis treatment
0,216  0,032  Neuropathy treatment
0,184  0,001  Sodium/glucose cotransporter 1 inhibitor
0,186  0,005  Phosphodiesterase VI inhibitor
0,227  0,047  Diabetic retinopathy treatment
0,224  0,046  Sepsis treatment
0,220  0,043  Thrombolytic
0,181  0,005  Glutamate release inhibitor
0,212  0,038  Muscular dystrophy treatment
0,231  0,057  Wound healing agent
0,223  0,052  P-glycoprotein inhibitor
0,172  0,003  Antimycoplasmal
0,181  0,013  Carcinogenic, group 2A
0,177  0,011  Thioredoxin inhibitor
0,171  0,018  Antispirochetal
0,164  0,013  Transcription factor NF kappa B stimulant
0,270  0,121  Antiprotozoal (Plasmodium)
0,213  0,065  Sedative
0,167  0,021  Antineoplastic (uterine cancer)
0,183  0,039  Alpha-N-acetylglucosaminidase inhibitor
0,180  0,043  Carcinogenic, group 3
0,141  0,008  Na+ K+ transporting ATPase inhibitor
0,142  0,008  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,232  0,102  Antituberculosic
0,273  0,144  Antineoplastic (myeloid leukemia)
0,238  0,109  CYP1A2 substrate
0,149  0,021  Alcohol dehydrogenase inhibitor
0,135  0,008  Protein 50S ribosomal subunit inhibitor
0,154  0,028  HDL-cholesterol increasing
0,136  0,010  Antiviral (Dengue virus)
0,137  0,011  ATPase (Vacuolar H+) inhibitor
0,182  0,059  Antineoplastic (bone cancer)
0,180  0,059  Eye irritation, high
0,156  0,035  Microtubule formation inhibitor
0,139  0,019  Antiviral (Trachoma)
0,141  0,023  Triose-phosphate isomerase inhibitor
0,163  0,048  Neurotrophic factor
0,145  0,030  Carbonic anhydrase III inhibitor
0,156  0,043  Antiviral (Hepatitis B)
0,152  0,040  Growth stimulant
0,151  0,039  Interleukin 1b antagonist
0,122  0,014  Aldose reductase inhibitor
0,160  0,054  Alkaline phosphatase inhibitor
0,166  0,060  Hair growth stimulant
0,150  0,045  Heat shock protein 70 antagonist
0,147  0,042  Beta amyloid protein antagonist
0,121  0,018  Glycine receptor antagonist
0,111  0,009  Interferon inducer
0,166  0,065  Protein-tyrosine phosphatase inhibitor
0,125  0,025  Interleukin 12 antagonist
0,157  0,058  Antiacne
0,103  0,004  Heparanase inhibitor
0,187  0,088  Pyruvate kinase inhibitor
0,196  0,097  Hypolipemic
0,143  0,045  Gastritis treatment
0,116  0,019  Histone deacetylase SIRT1 stimulant
0,116  0,019  Histone deacetylase stimulant
0,129  0,033  Uric acid excretion stimulant
0,102  0,006  Alpha-mannosidase inhibitor
0,097  0,003  Protein 30S ribosomal subunit inhibitor
0,225  0,132  Bone diseases treatment
0,095  0,003  Antibiotic Aminoglycoside-like
0,146  0,054  Ca2+-transporting ATPase inhibitor
0,129  0,041  UGT2B1 substrate
0,088  0,003  Cholesterol absorption inhibitor
0,162  0,079  UGT2B10 substrate
0,174  0,091  Anesthetic general
0,111  0,028  Phosphofructokinase-1 inhibitor
0,129  0,046  Antifungal (Pneumocystis)
0,156  0,074  Carcinogenic, group 1
0,097  0,016  Xanthine dehydrogenase inhibitor
0,103  0,022  T cell inhibitor
0,140  0,060  Toll-Like receptor 2 antagonist
0,157  0,077  UGT1A3 substrate
0,128  0,048  Gout treatment
0,087  0,007  Mannosidase inhibitor
0,211  0,132  Antiischemic
0,137  0,060  Antihelmintic (Trematoda)
0,136  0,062  Retinoprotector
0,129  0,056  Protein-tyrosine phosphatase 1B inhibitor
0,200  0,127  Antiosteoporotic
0,184  0,112  Aryl hydrocarbon receptor agonist
0,097  0,027  HIV-1 integrase (3'-Processing) inhibitor
0,089  0,021  CDC25B inhibitor
0,128  0,060  Antiprotozoal (Amoeba)
0,096  0,030  CDC25A inhibitor
0,097  0,032  Thioredoxin reductase inhibitor
0,179  0,118  Platelet antagonist
0,073  0,013  Adenine nucleotide translocase inhibitor
0,076  0,018  Carbonic anhydrase XIV inhibitor
0,097  0,039  NAD(P)H dehydrogenase (quinone) inhibitor
0,108  0,051  Sphingomyelinase inhibitor
0,085  0,029  HIV-1 integrase (Strand Transfer) inhibitor
0,106  0,050  UGT2B11 substrate
0,067  0,014  Glucose-6-phosphate isomerase inhibitor
0,259  0,206  Alzheimer's disease treatment
0,174  0,121  Antiviral (HIV)
0,052  0,001  Antibiotic Anthracycline-like
0,111  0,063  Chelator
0,098  0,051  SULT1E1 substrate
0,075  0,029  Neuraminidase (influenza) inhibitor
0,048  0,003  Vanilloid 2 agonist
0,110  0,065  EphA2 antagonist
0,090  0,046  Carbonic anhydrase VI inhibitor
0,082  0,038  Antitreponemal
0,063  0,021  Glucose-6-phosphate translocase inhibitor
0,060  0,019  Equilibrative nucleoside transport protein inhibitor
0,071  0,031  Nitric oxide donor
0,085  0,047  Cell adhesion molecule inhibitor
0,042  0,004  Toll-Like receptor 4 agonist
0,048  0,011  Melatonin 2 agonist
0,181  0,145  Huntington's disease treatment
0,110  0,074  Estrogen antagonist
0,130  0,095  Antidiabetic (type 1)
0,119  0,085  Toll-Like receptor antagonist
0,045  0,011  Nucleoside transporters inhibitor
0,062  0,029  Estrogen agonist
0,132  0,100  UGT2B9 substrate
0,193  0,163  Metabolic disease treatment
0,055  0,027  Phosphorylase inhibitor
0,200  0,174  CTGF expression inhibitor
0,074  0,049  Lipase inhibitor
0,084  0,060  Vanilloid agonist
0,068  0,048  Gaucher disease treatment
0,057  0,038  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,125  0,106  UGT1A4 substrate
0,045  0,026  Guanylate cyclase inhibitor
0,054  0,037  Leukotriene B4 antagonist
0,180  0,163  CYP2D6 substrate
0,055  0,038  Postmenopausal disorders treatment
0,083  0,067  Interleukin 5 antagonist
0,126  0,110  Adenylate cyclase stimulant
0,107  0,092  Cyclooxygenase 1 inhibitor
0,021  0,006  Telomerase stimulant
0,059  0,044  Neuraminidase inhibitor
0,141  0,130  Antiviral (Hepatitis)
0,017  0,007  Antibiotic Tetracycline-like
0,056  0,046  Lipocortins synthesis agonist
0,184  0,174  Gastrin inhibitor
0,047  0,038  Topoisomerase II beta inhibitor
0,034  0,025  Adenosine uptake inhibitor
0,070  0,061  GABA aminotransferase inhibitor
0,104  0,097  Tubulin antagonist
0,016  0,009  Antibiotic Macrolide-like
0,027  0,020  Uridine phosphorylase inhibitor
0,047  0,042  Factor III inhibitor
0,027  0,023  1,3-Beta-glucan synthase inhibitor
0,046  0,042  Cytokine production stimulant
0,022  0,019  Adenosine A1 receptor agonist
0,039  0,038  DNA gyrase subunit A inhibitor
0,020  0,020  GRP78 expression inhibitor

